{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:33:57Z","timestamp":1787610837487,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jmii.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T19:01:56Z","timestamp":1630782116000},"page":"888-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["In\u00a0vitro activity of cefiderocol, cefepime\/enmetazobactam, cefepime\/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018\u20132020"],"prefix":"10.1016","volume":"55","author":[{"given":"Po-Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Sen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hsing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muh-Yong","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lih-Shinn","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hui","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2021.08.012_bib1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jac\/dkab008","article-title":"A comprehensive assessment of carbapenem use across 90 Veterans Health Administration hospitals with defined stewardship strategies for carbapenems","volume":"76","author":"Suzuki","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jmii.2019.04.008","article-title":"Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia","volume":"52","author":"Liu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","article-title":"Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options","volume":"10","author":"Sheu","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2021.08.012_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/jcm9010275","article-title":"Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia","volume":"9","author":"Jean","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmii.2021.08.012_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jmii.2019.08.017","article-title":"Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period","volume":"52","author":"Feng","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib6","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1038\/srep11715","article-title":"Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2021.08.012_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jmii.2019.03.004","article-title":"Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia","volume":"52","author":"Chusri","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib8","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid2507.181200","article-title":"Carbapenem-resistant Pseudomonas aeruginosa at US emerging infections program sites, 2015","volume":"25","author":"Walters","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2021.08.012_bib9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ajic.2019.03.003","article-title":"Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis","volume":"47","author":"Du","year":"2019","journal-title":"Am J Infect Contr"},{"key":"10.1016\/j.jmii.2021.08.012_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jmii.2014.10.006","article-title":"Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"49","author":"Liu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkaa478","article-title":"Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time","volume":"76","author":"Baltas","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jac\/dky019","article-title":"Discovery and development of new antibacterial drugs: learning from experience?","volume":"73","author":"Jackson","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dky425","volume":"74","author":"Hsueh","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/IDR.S193638","volume":"12","author":"Liao","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jmii.2021.08.012_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205166","article-title":"Introduction and geographic availability of new antibiotics approved between 1999 and 2014","volume":"13","author":"Kallberg","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.jmii.2021.08.012_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciw201","article-title":"Emerging resistance, new antimicrobial agents but no tests! the challenge of antimicrobial susceptibility testing in the current US regulatory landscape","volume":"63","author":"Humphries","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.08.012_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"Suppl S1","key":"10.1016\/j.jmii.2021.08.012_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf807","article-title":"The need for antimicrobial resistance surveillance","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib19","series-title":"Performance standards for antimicrobial susceptibility testing: 30th informational supplement M100-ED31","year":"2021"},{"key":"10.1016\/j.jmii.2021.08.012_bib20","doi-asserted-by":"crossref","first-page":"e00514","DOI":"10.1128\/AAC.00514-19","article-title":"In\u00a0vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from U.S. and European hospitals during 2014-2015","volume":"63","author":"Morrissey","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jmii.2018.03.001","article-title":"A multicenter study on clinical characteristics of Acinetobacter bacteremia in patients with liver cirrhosis","volume":"52","author":"Liu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jmii.2019.06.008","article-title":"An unusual community-acquired invasive and multi systemic infection due to ExoU-harboring Pseudomonas aeruginosa strain: clinical disease and microbiological characteristics","volume":"53","author":"Elabbadi","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jmii.2019.08.007","article-title":"Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"53","author":"Zheng","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau4679","article-title":"The challenge of antimicrobial resistance: what economics can contribute","volume":"364","author":"Roope","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jmii.2021.08.012_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.coph.2011.07.005","article-title":"Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics","volume":"11","author":"Martinez","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jmii.2021.08.012_bib26","doi-asserted-by":"crossref","first-page":"ofaa083","DOI":"10.1093\/ofid\/ofaa083","article-title":"A broken antibiotic market: review of strategies to incentivize drug development","volume":"7","author":"Bhavnani","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2021.08.012_bib27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/jac\/dkab015","article-title":"Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections","volume":"76","author":"Parsels","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/14787210.2019.1612240","article-title":"Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria","volume":"17","author":"Jean","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jmii.2021.08.012_bib29","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/jac\/dkx136","article-title":"Activity of ceftolozane\/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles","volume":"72","author":"Livermore","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12866-016-0719-2","article-title":"Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan","volume":"16","author":"Kao","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jmii.2021.08.012_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01726-20","volume":"65","author":"Yang","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib32","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1093\/ofid\/ofx163.896","article-title":"Activity of the novel extended-spectrum \u03b2-Lactamase inhibitor AAI101 in combination with cefepime towards a challenge panel of Acinetobacter baumannii","volume":"4","author":"Morrissey","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2021.08.012_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00018-17","article-title":"Surveillance of omadacycline activity against clinical isolates from a global collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib34","article-title":"In\u00a0vitro activity of eravacycline against gram-negative bacilli isolated in clinical laboratories worldwide from 2013 to 2017","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.08.012_bib35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/ciz394","article-title":"Omadacycline: a modernized tetracycline","volume":"69","author":"Gallagher","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.08.012_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/CMR.00066-16","article-title":"Antimicrobial stewardship: how the microbiology laboratory can right the ship","volume":"30","author":"Morency-Potvin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2021.08.012_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmii.2018.05.007","article-title":"Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient","volume":"52","author":"Su","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib38","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1128\/JCM.00635-16","article-title":"Impact of delays between clinical and laboratory Standards Institute and Food and drug administration revisions of interpretive criteria for carbapenem-resistant Enterobacteriaceae","volume":"54","author":"Bartsch","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2021.08.012_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","article-title":"The threat of antimicrobial resistance in developing countries: causes and control strategies","volume":"6","author":"Ayukekbong","year":"2017","journal-title":"Antimicrob Resist Infect Contr"},{"key":"10.1016\/j.jmii.2021.08.012_bib40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jmii.2020.04.009","article-title":"Pseudomonas aeruginosa sepsis presenting as oral ecthyma gangrenosum in identical twins with Bruton tyrosine kinase gene mutation: two case reports and review of the literature","volume":"53","author":"Lin","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.08.012_bib41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jmii.2019.09.007","article-title":"The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: a hospital-based retrospective comparative analysis of genotypically identified strains","volume":"52","author":"Koizumi","year":"2019","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:28:12Z","timestamp":1761658092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118221001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1684118221001869"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2021.08.012","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro activity of cefiderocol, cefepime\/enmetazobactam, cefepime\/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018\u20132020","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}